Dr. Ali Mostajelean is a Oakland, California based neurologist who is specialized in Child Neurology. Active license number of Dr. Ali Mostajelean is A90764 for Child Neurology in California. His current practice location is 747 52nd St, Neurology Department, Oakland. Patients can reach him at 510-428-3590. Dr. Ali Mostajelean is M.D. in Child Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1174848238. Dr. Ali Mostajelean specializes in neurology with special skills in diagnosis and treatment of neurologic disorders of the neonatal period, infancy, early childhood, and adolescence.
Complete Profile:
Dr. Ali Mostajelean speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1174848238
NPI Enumeration Date:
01 Apr, 2010
NPI Last Update On:
04 Apr, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Ali Mostajelean are as mentioned below.
License Number
Specialization
State
Status
A90764
Child Neurology
California
Primary
A90764
Clinical Neurophysiology
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Ali Mostajelean 747 52nd St, Neurology Department Oakland, California
Zip:
94609-1809
Phone Number:
510-428-3590
Patients can reach Dr. Ali Mostajelean at 747 52nd St, Neurology Department, Oakland, California or can call to book an appointment on 510-428-3590.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.